Women-specific HIV/AIDS services: Identifying and defining the components of holistic service delivery for women living with HIV/AIDS

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Carter, Allison J ^a,b   Bourgeois, Sonya ^c   O'Brien, Nadia ^d   Abelsohn, Kira ^c   Tharao, Wangari ^e   Greene, Saara ^f   Margolese, Shari ^c   Kaida, Angela ^a   Sanchez, Margarite ^g   Palmer, Alexis K ^a,b   Cescon, Angela ^b   De Pokomandy, Alexandra ^d   Loutfy, Mona R ^c  

^a SIMON FRASER UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e Women's Health in Women's Hands Community Health Centre   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g ViVA   (Canada)

Author keywords

CHIWOS; Gender; Health services; HIV; HIV AIDS programming; Women; Women centred care; Women specific services

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; AUSTRALIA; CANADA; FAMILY COUNSELING; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOLISTIC CARE; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH; MENTAL HEALTH SERVICE; PATIENT CARE PLANNING; PATIENT SAFETY; PEER ACCEPTANCE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; REVIEW; SOCIAL CARE; SOCIAL INTERACTION; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; WOMEN'S HEALTH; WORK ENVIRONMENT; CHIWOS; FEMALE; GENDER; HEALTH SERVICE; HIV/AIDS PROGRAMMING; HUMAN IMMUNODEFICIENCY VIRUS; WOMEN-CENTRED CARE; WOMEN-SPECIFIC SERVICES;

CHIWOS; GENDER; HEALTH SERVICES; HIV; HIV/AIDS PROGRAMMING; WOMEN; WOMEN-CENTRED CARE; WOMEN-SPECIFIC SERVICES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HUMANS; WOMEN'S HEALTH SERVICES;

MLCS; MLOWN;

EID: 84879567089     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.17433     Document Type: Review

References (104)

1. UNAIDS. Annex 1: HIV and AIDS estimates and data, 2009 and 2001. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva: UNAIDS; 2010.
2. Lin K, McElmurry BJ, Christiansen C. Women and HIV/AIDS in China: gender and vulnerability. Health Care Women Int. 2007;28:680-99.
3. Wang L, Wang N, Li D, Jia M, Gao X, Qu S, et al. The 2007 estimates for people at risk for and living with HIV in China: progress and challenges. J Acquir Immune Defic Syndr. 2009;50(4):414.
4. Public Health Agency of Canada. HIV/AIDS epi updates, July 2010. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2010.
5. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010.
6. Hankins C. Gender, sex, and HIV: how well are we addressing the imbalance? Current Opinion in HIV and AIDS. 2008;3(4):514-20.
7. Cohen MS. Preventing sexual transmission of HIV. Clin Infect Dis. 2007;45(Suppl 4):S287-S92.
8. Gupta GR. Gender, sexuality, and HIV/AIDS: the what, the why, and the how. HIV/AIDS Policy Law Rev. 2000;5(4):86-93.
9. Gupta GR. How men's power over women fuels the HIV epidemic. Br Med J. 2002;324(7331):183-4.
10. Wu E, El-Bassel N, Witte SS, Gilbert L, Chang M. Intimate partner violence and HIV risk among urban minority women in primary health care settings. AIDS Behav. 2003;7(3):291-301.
11. El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61(1):171-83.
12. Gilbert L, El-Bassel N, Rajah V, Foleno A, Fontdevila J, Frye V, et al. The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment. Mount Sinai J Med. 2000;67(5-6):452-64.
13. Weiss E, Gupta GR. Bridging the gap: addressing gender and sexuality in HIV prevention.Washington DC: International Centre for Research on Women; 1998.
14. Blanc AK. The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence. Stud Fam Plann. 2001;32(3):189-213.
15. Le Franc E, Wyatt GE, Chambers C, Eldemire D, Bain B, Ricketts H.Working women's sexual risk taking in Jamaica. Soc Sci Med. 1996;42(10):1411-7.
16. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. J Am Med Assoc. 1999;281(24):2305-15.
17. Anderson KH, Mitchell JM. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med. 2000;160(20):3114-20.
18. Sohler NL, Li X, Cunningham CO. Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS. 2009;23(9):775-83.
19. Puskas CM, Forrest JI, Parashar S, Salters KA, Cescon AM, Kaida A, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports. 2011:1-11.
20. Wood E, Montaner JSG, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis. 2003;188(8):1164-70.
21. Strathdee SA, Palepu A, Cornelisse PGA, Yip B, O'Shaughnessy MV, Montaner JSG, et al. Barriers to use of free antiretroviral therapy in injection drug users. J Am Med Assoc. 1998;280(6):547-9.
22. Tapp C, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg RS, Montaner J, Wood E. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86-93.
23. Carr RL, Gramling LF. Stigma: a health barrier for women with HIV/AIDS. J Assoc Nurses AIDS Care. 2004;15(5):30-9.
24. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20(5):359-68.
25. Lichtenstein B. Domestic violence in barriers to health care for HIV-positive women. AIDS Patient Care STDS. 2006;20(2):122-32.
26. Gahagan J, Loppie C. Counting pills or counting on pills? What HIV + women have to say about antiretroviral therapy. Canadian Woman Studies. 2001;21(2):118-23.
27. Cunningham WE, Hays RD, Williams KW, Beck KC, Dixon WJ, Shapiro MF. Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med Care. 1995:739-54.
28. Moneyham L, McLeod J, Boehme A, Wright L, Mugavero M, Seal P, et al. Perceived barriers to HIV care among HIV-infected women in the deep South. J Assoc Nurses AIDS Care. 2010;21(6):467-77.
29. Sargeant S, Jones E. Barriers in access to primary health care for young HIV+ women: a qualitative research study. Vancouver: YouthCO AIDS Society and Positive Women's Network; 2008.
30. Kellington S, the Listen Up! Project Advisory Group. Listen up! Women are talking about . . . Women's health research phase 1 report. Vancouver: AIDS Vancouver and Positive Women's Network; 1999.
31. Quinn E. Leadership, engagement, action and dialogue project: final report. Vancouver: Positive Women's Network; 2010.
32. Sowell R, Seals B, Moneyham L, Guillory J, Demi A, Cohen L. Barriers to health-seeking behaviors for women infected with HIV. Nursingconnections. 1996;9(3):5-17.
33. Csete J. Vectors, vessels and victims: HIV/AIDS and women's human rights in Canada. Toronto: Canadian HIV/AIDS Legal Network; 2005.
34. Seals BF, Sowell RL, Demi AS, Moneyham L, Cohen L, Guillory J. Falling through the cracks: Social service concerns of women infected with HIV. Qual Health Res. 1995;5(4):496-515.
35. Reif S, Golin C, Smith S. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care. 2005;17(5):558-65.
36. Stein M, Crystal S, Cunningham W, Ananthanarayanan A, Andersen R, Turner BJ, et al. Delays in seeking HIV care due to competing caregiver responsibilities. Am J Public Health. 2000;90(7):1138-40.
37. Schuster MA, Kanouse DE, Morton SC, Bozzette SA, Miu A, Scott GB, et al. HIV-infected parents and their children in the United States. Am J Public Health. 2000;90(7):1074-81.
38. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre-and highly active antiretroviral therapy eras. AIDS. 2005;19(4):357.
39. Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother. 2007;60(4):724-32.
40. Cescon A, Cooper C, Chan K, Palmer A, Klein M, Machouf N, et al. Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort. HIV medicine. 2011;12(6):352-60.
41. Hoen B, Fournier I, Lacabaratz C, Burgard M, Charreau I, Chaix ML, et al. Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005;40(3):307-16.
42. Bedimo R, Chen RY, Westfall AO, Raper JL, Allison JJ, Saag MS. Sustained HIV viral suppression following treatment interruption: an observational study. AIDS Res Hum Retroviruses. 2006;22(1):40-4.
43. Kaleebu P, Pillay D, Walker A, Robertson V, Gale C, Enzama R, et al. Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. AIDS. 2006;20(10):1391-9.
44. Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, Konde-Lule J, et al. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care. 2010;22(3):271-8.
45. Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS. 2005;19(6):577-83.
46. Moore AL, Kirk O, Johnson AM, Katlama C, Blaxhult A, Dietrich M, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr. 2003;32(4):452-61.
47. Kuyper LM, Wood E, Montaner JSG, Yip B, O'Connell JM, Hogg RS. Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort. J Acquir Immune Defic Syndr. 2004;37(4):1470-6.
48. Mocroft A, Gill M, Davidson W, Phillips A. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr. 2000;24(5):475-82.
49. O'Connell JM, Braitstein P, Hogg RS, Yip B, Craib K, O'Shaughnessy MV, et al. Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme. Antiviral Ther. 2003;8(6):569-76.
50. Cejtin HE. Gynecologic issues in the HIV-infected woman. Infect Dis Clin North Am. 2008;22(4):709-39.
51. Clark RA, Dumestre J.Women and human immunodeficiency virus: unique management issues. Am J Med Sci. 2004;328(1):17-25.
52. Robinson JA, Jamshidi R, Burke AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012.
53. Ogilvie GS, Palepu A, Remple VP, Maan E, Heath K, MacDonald G, et al. Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS. 2007;21:S83.
54. Castro DR, Le Gall JM, Andreo C, Spire B. Stigma, discrimination, and sexual (dis) satisfaction among people living with HIV: results from the "AIDES et toi" survey. AIDS Care. 2010;22(8):961-9.
55. Women for Positive Action. Learning guide: HIV, contraception, conception and pregnancy. Women for Positive Action; 2009 [cited 2012 October 18]; Available from: www.womenforpositiveaction.org/.../Learning%20guide%20HIV, %20conception,%20pregnancy%20and%20contraception200110.pdf
56. Benoit C, Shumka L. Gendering the population health perspective: fundamental determinants of women's health. Final report prepared for the Women's Health Research Network. Vancouver, BC; 2007.
57. Wuest J, Merritt-Gray M, Berman H, Ford-Gilboe M. Illuminating social determinants of women's health using grounded theory. Health Care Women Int. 2002;23:794-808.
58. Collins PH. It's all in the family: intersections of gender, race, and nation. Hypatia. 1998;13(3):62-82.
59. Hankivsky O, Christoffersen A. Intersectionality and the determinants of health: a Canadian perspective. Critical Public Health. 2008;18(3): 271-83.
60. Greene S, Chambers L, Masinde K, Mukandoli C. Housing as HIV prevention and support of and for HIV-positive mothers in Canada: The way forward. In: Gahagan J, editor.Women and HIV prevention in Canada. Toronto: Canadian Scholars Press; 2013.
61. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Social Res Methodology. 2005;8(1):19-32.
62. Grella CE. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs. 2008;Suppl 5:327-43.
63. Selbin J, Del Monte M.Waiting room of their own: the family care network as a model for providing gender-specific legal services to women with HIV, A. Duke J Gender Law & Policy. 1998;5:103-32.
64. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29(1):19-53.
65. Bride BE. Single-gender treatment of substance abuse: effect on treatment retention and completion. Soc Work Res. 2001;25(4):223-32.
66. Campbell CI, Alexander JA, Lemak CH. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009;37(1):64-72.
67. Center for Women Policy Studies. Building a national policy agenda: ten principles for women-focused HIV/AIDS prevention.Washington, DC: Center for Women Policy Studies; 1996.
68. Claus RE, Orwin RG, Kissin W, Krupski A, Campbell K, Stark K. Does gender-specific substance abuse treatment for women promote continuity of care? J Subst Abuse Treat. 2007;32(1):27-39.
69. Niccols A, Milligan K, Sword W, Thabane L, Henderson J, Smith A, et al. Maternal mental health and integrated programs for mothers with substance abuse issues. Psychol Addictive Behav. 2010;24(3):466-74.
70. Poehlmann J, White T, Bjerke K. Integrating HIV risk reduction into family programs for women offenders: a family relationship perspective. Family Relations. 2004;53(1):26-37.
71. Parrish M, Burry C, Pabst MS. Providing comprehensive case management services to Urban women with HIV/AIDS and their families. Affilia. 2003;18(3):302-15.
72. Dodds S, Nuehring EM, Blaney NT, Blakley T, Lizzotte JM, Lopez M, et al. Integrating mental health services into primary HIV care for women: the Whole Life project. Public Health Rep. 2004;119(1):48-59.
73. Jarrett EM, Yee BWK, Banks ME. Benefits of comprehensive health care for improving health outcomes in women. Professional Psychol: Res Pract. 2007;38(3):305-13.
74. Wisdom JP, Hoffman K, Rechberger E, Seim K, Owens B. Women-focused treatment agencies and process improvement: strategies to increase client engagement. Women Ther. 2008;32(1):69-87.
75. Chung S, Domino ME, Morrissey JP. Changes in treatment content of services during trauma-informed integrated services for women with co-occurring disorders. Community Ment Health J. 2009;45(5):375-84.
76. Exner TM, Hoffman S, Dworkin SL, Ehrhardt AA. Beyond the male condom: the evolution of gender-specific HIV interventions for women. Annu Rev Sex Res. 2003;14:114-36.
77. Goicoechea-Balbona A, Barnaby C, Ellis I, Foxworth V. AIDS: the development of a gender appropriate research intervention. Soc Work Health Care. 2000;30(3):19-37.
78. Wechsberg WM, Lam WKK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health. 2004;94(7):1165-73.
79. Grella CE, Polinsky ML, Hser YI, Perry SM. Characteristics of women-only and mixed-gender drug abuse treatment programs. J Subst Abuse Treat. 1999;17(1):37-44.
80. Boyd-Franklin N, Steiner GL, Boland M. Children, families, and HIV/AIDS: psychosocial and therapeutic issues. New York: The Guilford Press; 1995.
81. Vancouver/Richmond Health Board. A framework for women centred health. Vancouver: Vancouver/Richmond Health Board; 2001.
82. Shannon K, Bright V, Duddy J, Tyndall MW. Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health. 2005;82(3):488-97.
83. Rolfe DE, Sutton EJ, Landry M, Sternberg L, Price JAD. Women's experiences accessing a women-centered cardiac rehabilitation program: a qualitative study. J Cardiovasc Nurs. 2010;25(4):332-41.
84. Kent H. Family-friendly HIV and AIDS care the goal at Vancouver's Oak Tree Clinic. Can Med Assoc J. 1996;154(9):1407-9.
85. Positive Women's Network. Why are women-exclusive services needed? n.d.
86. Metcalfe KA, Langstaff JE, Evans SJ, Paterson HM, Reid JL. Meeting the needs of women living with HIV. Public Health Nurs. 1998;15(1):30-4.
87. Mason R. Building women's social citizenship: a five-point framework to conceptualise the work of women-specific services in rural Australia,Women's. Studies Int Forum. 2007;30:299-312.
88. Judd F, Armstrong S, Kulkarni J. Gender-sensitive mental health care. Austral Psychiatry. 2009;17(2):105-11.
89. Long CG, Fulton B, Fitzgerald KA, Hollin CR. Group substance abuse treatment for women in secure services. Ment Health Substance Use: Dual Diagnosis. 2010;3(3):227-37.
90. Katz DA. The profile of HIV infection in women: a challenge to the profession. Soc Work Health Care. 1997;24(3/4):127-34.
91. Yano EM, Goldzweig C, Canelo I,Washington DL. Diffusion of innovation in women's health care delivery: the Department of Veterans Affairs' adoption of women's health clinics. Women's Health Issues. 2006;16(5):226-35.
92. Phillips S. The social context of women's health: goals and objectives for medical education. Can Med Assoc J. 1995;152(4):507-11.
93. Aral SO, Mann JM. Commercial sex work and STD: the need for policy interventions to change societal patterns. Sex Transm Dis. 1998;25(9):455-6.
94. Peterson JL. The Challenges of Seeking and Receiving Support for Women Living With HIV. Health Communication. 2010;25(5):470-9.
95. UNAIDS. From principle to practice: greater involvement of people living with or affected by HIV/AIDS (GIPA). Geneva: UNAIDS; 1999.
96. UNAIDS. 2004 Report on the global HIV/AIDS epidemic: 4th global report. Geneva: UNAIDS; 2004.
97. Spittal P, Bruneau J, Craib K, Miller C, Lamothe F,Weber A, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003;15(2): 187-95.
98. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308(5728):1582-3.
99. Kellington S, Blackwind T, Desroches M, Jir B, King N, Kjar G, et al. Listen up! Women are talking about . . . Women's health research project phase 2 report. Vancouver: AIDS Vancouver and Positive Women's Network; 2000.
100. d'Arminio Monforte A, González L, Haberl A, Sherr L, Ssanyu-Sseruma W, Walmsley SL. Better mind the gap: addressing the shortage of HIV-positive women in clinical trials. AIDS. 2010;24(8):1091-4.
101. Stipzer DL. Gender and sex-based analysis in health research: a guide for CIHR researchers and reviewers. Ottawa: Canadian Institutes of Health Research; 2007.
102. Raphael D. Social determinants of health: Canadian perspectives, 2nd ed. Toronto: Canadian Scholars' Press; 2009.
103. Health Canada. Strategies for populaton health: investing in the health of Canadians. Ottawa: Health Canada; 1994.
104. Yamin A. Transformative combinations: women's health and human rights. Am Med Women's Assoc. 1997;52:169-73.